Reuters logo
BRIEF-Valeant receives lender consent for refinancing, amendment of credit agreement
March 10, 2017 / 9:55 PM / 6 months ago

BRIEF-Valeant receives lender consent for refinancing, amendment of credit agreement

March 10 (Reuters) - Valeant Pharmaceuticals International Inc:

* Valeant receives lender consent for refinancing and amendment of credit agreement

* Valeant - obtained requisite lender approval for previously announced amendment of company’s existing credit agreement

* Valeant - credit agreement amendment is expected to become effective concurrently with funding of new term b loans on or about March 21, 2017

* Valeant - obtained requisite lender approval for amendment of existing credit agreement to facilitate borrowing of new term b loans that mature in 2022 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below